A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览7
暂无评分
关键词
oncolytic immunotherapy,cutaneous metastases,solid tumors,radiotherapy,t-vec
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要